Arpida AG

International public company
Duggingerstrasse 23, Reinach,  CH-4153, Switzerland
()41 061 417 96 60, 41 061 417 96 61 fax, http://www.arpida.ch/

Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Biopharmaceutical company with interests in the research, development, manufacture and distribution of antibacterial drugs

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Arpida AG, News and Information

Gentium Announces New Board of Directors and Interim CEO.
Business Wire; 11/9/2009; 1248 words; ...Khalid Islam - Former President and Chief Executive Officer of Arpida Ltd, has held various executive functions in Marion Merrell...pharmaceutical industries. Dr. Islam is the founder of Ki Consulting AG and co-founder of Sirius Healthcare Partners GmbH, both of...

Other News To Note.
BIOWORLD Today; 11/3/2009; 2342 words; ...of Hepatology. A prodrug form of isatoribine is being developed by Anadys and partner, Novartis AG, of Basel, Switzerland, to treat HCV. o Arpida Ltd., of Basel, Switzerland, said the FDA granted fast-track status to intravenous iclaprim...

Activaero Closes a [euro] 10.7 Million ($16 million) Series A Financing.
Business Wire; 10/29/2009; 1402 words; ...solutions for solid dosage forms. About BioMedPartners AG BioMedPartners AG is a leading independent European venture capital firm...have already either successfully completed an IPO (Arpida AG, Santhera Pharmaceuticals AG) or have been acquired...

Other News To Note.(Bio-Rad Laboratories Inc. acquires Biotest AG)(Eurogentec acquires AnaSpec Inc)(EMD Chemicals Inc. collabrate with MitoSciences Inc.)
BIOWORLD Today; 10/26/2009; 1570 words; o Arpida A/S, of Reinach, Switzerland, withdrew...recommending iclaprim's approval in the U.S. Arpida, which laid off most of its work force earlier...certain diagnostic businesses of Biotest AG, of Dreieich, Germany, for C45 million...

Evolva Closes $27.8M Series B as Arpida Merger Plans Solidify.(Eurand NV)
BIOWORLD Today; 10/23/2009; 1154 words; ...as part of its move to merge with Arpida AG. Evolva said it is continuing in...closing after approval of the merger by Arpida shareholders. The Series B funding...Sunstone Capital. The beleaguered Arpida and Evolva agreed to the merger in...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.